SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE:A) today introduced the 708-DS Dissolution Apparatus, a quality control instrument that can be configured for manual and ...

Agilent Technologies Inc. has introduced the 280-DS Mechanical Qualification System, a new instrument for routine and effortless calibration of a dissolution apparatus. The 280-DS accurately measures, ...

The Pharmaceutical Dissolution Testing Services Market is poised for significant growth, with a projected market value of US$1.53 billion by 2033. This surge represents a substantial increase from the ...

Agilent Technologies Inc. has introduced an enhanced version of its Dissolution Workstation Software, providing better data integration, method change control and instrument monitoring for controlling ...

Dissolution and drug release tests are directly relevant to the safety and efficacy of many common pharmaceutical dosage forms. To achieve reliable and reproducible results, analysts must understand ...

The All India Pharmaceutical Associations Consortium (AIPAC), in association with Small & Medium Pharmaceutical Industry Centre (SMPIC), NIPER Mohali – SAS Nagar, Punjab, Society for Pharmaceutical ...

To achieve reliable and reproducible results, it is important that analysts understand the importance of correctly setting up and sampling from the chosen apparatus. In addition to use of dissolution ...